Neurophos key facts
as of Oct 2026- Manufacturer of an optical processor designed to bypass the resistive losses of pushing currents through circuits to gain efficiency.
- Neurophos is valued at approximately $310.0M as of Oct 2026, set at its Series A, Jan 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $119.2M across 5 recorded rounds; the latest was Later Stage VC (Series A) ($109.2M) in Jan 2026.
- Notable investors include Alumni Ventures, Mana Ventures, Gaingels, Realm Capital Ventures, Aramco Ventures — 29 tracked in total.
- 4 investment vehicles were formed to buy Neurophos shares in the last 12 months, reporting $4.1M sold to 163 investors, per SEC Form D filings.
- Neurophos has filed 1 Form D with the SEC, most recently Mar 2026 ($109.2M sold to 44 investors).
- Status: Privately Held (backing).
Valued at $310.0M at its Series A, Jan 2026. Nothing has traded since.
- ·Post-money valuations for 4 rounds
- ·The complete investor list: 29 names
- ·Watch Neurophos: the Monday email on marks, rounds and moves
Neurophos funding rounds
5 roundsVehicles formed to buy Neurophos shares
secondary demand · SEC Form D filingsIn the last 12 months, 4 investment vehicles were formed to buy Neurophos shares, reporting $4.1M sold to 163 investors across 4 sponsors. Most recent filing Dec 2025.
Membership and data by Private Market View
Neurophos leadership
- Patrick Bowen Ph.DCo-Founder & Chief Executive Officer
- Preston WooChief Financial Officer
- Tom Driscoll Ph.DCo-Founder & Co-Chief Technology Officer
- Hod Finkelstein Ph.DCo-Chief Technology Officer
Who backs Neurophos
29+Membership and data by Private Market View
Neurophos valuation
Neurophos was valued at $310 million at its Series A in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Neurophos raised?
Neurophos has raised $119 million across 5 recorded rounds since 2021. The largest was a $7.2 million seed round in Mar 2024; the most recent was a $109 million Series A in Jan 2026. 4 of the rounds disclosed a post-money valuation.
Neurophos has filed 1 Form D with the SEC, most recently in Mar 2026 ($109 million sold to 44 investors).
Institutional holders and vehicles
In the last 12 months, 4 investment vehicles were formed to buy Neurophos shares, reporting $4.1 million sold to 163 investors across 4 sponsors, per SEC Form D filings (most recent Dec 2025).
Neurophos investors
29 investors are on record for Neurophos, including Alumni Ventures, Mana Ventures, Gaingels and Realm Capital Ventures. By type, the record holds 12 venture capital firms and 2 funds of funds. The Series A in Jan 2026 drew 22 investors.
Who runs Neurophos
7 people are listed on the Neurophos team: 5 executives and 2 board members, including Andrew Traverso Ph.D (Co-Founder) and Patrick Bowen Ph.D (Co-Founder). 7 of them have a verified direct contact on file.
About Neurophos
Manufacturer of an optical processor designed to bypass the resistive losses of pushing currents through circuits to gain efficiency. The company's metasurfaces build the optical compute-in-memory system that works with sparse kernels in absolute and Fourier space, enabling clients to increase kernel size without power consumption or latency.
- Sector
- Information Technology
- HQ
- Austin, TX, United States
- Founded
- 2020
- Employees
- 38
- Website
- neurophos.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.